Dohui Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dohui Hwang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Byung Chul Yu
Division of Nephrology Soonchunhyang University Bucheon Hospital Gyeonggi‐do South Korea
1 shared publicationDong Cheol Han
Division of Nephrology Soonchunhyang University Seoul Hospital Seoul South Korea
1 shared publicationEun Young Lee
Division of Nephrology Soonchunhyang University Cheonan Hospital Chungcheongnam‐do South Korea
1 shared publication- Hyoungnae Kim
Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea
1 shared publication Hyo‐Wook Gil
Division of Nephrology Soonchunhyang University Cheonan Hospital Chungcheongnam‐do South Korea
1 shared publicationHyunjin Noh
Division of Nephrology Soonchunhyang University Seoul Hospital Seoul South Korea
1 shared publication
Latest Publications
- Open Access
- 24 February 2021
- Published by Wiley in Nephrology
- Vol. 26 (7) , 594-602
Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy
Background: Recently, a new international risk prediction model including the Oxford classification was published which was validated in a large multi‐ethnic cohort. Therefore, we aimed to validate this risk prediction model in Korean patients with IgA nephropathy.Methods: This retrospective cohort study was conducted with 545 patients who diagnosed IgA nephropathy with renal biopsy in three medical centers. The primary outcome was defined as a reduction in estimated glomerular filtration rate (eGFR) of >50% or incident end‐stage renal disease (ESRD). Continuous net reclassification improvement (cNRI) and integrated discrimination improvement (IDI) were used to validate models.Results: During the median 3.6 years of follow‐up period, 53 (9.7%) renal events occurred. In multivariable Cox regression model, M1 (hazard ratio [HR], 2.22; 95% confidence interval [CI], 1.02–4.82; p = .043), T1 (HR, 2.98; 95% CI, 1.39–6.39; p = .005) and T2 (HR, 4.80; 95% CI, 2.06–11.18; p < .001) lesions were associated with increased risk of renal outcome. When applied the international prediction model, the area under curve (AUC) for 5‐year risk of renal outcome was 0.69, which was lower than previous validation and internally derived models. Moreover, cNRI and IDI analyses showed that discrimination and reclassification performance of the international model was inferior to the internally derived models.Conclusion: The international risk prediction model for IgA nephropathy showed not as good performance in Korean patients as previous validation in other ethnic group. Further validation of risk prediction model is needed for Korean patients with IgA nephropathy.
- 24 February 2021
- Published by Wiley in Nephrology
- Vol. 26 (7) , 594-602
Open AccessValidation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy
Background: Recently, a new international risk prediction model including the Oxford classification was published which was validated in a large multi‐ethnic cohort. Therefore, we aimed to validate this risk prediction model in Korean patients with IgA nephropathy.Methods: This retrospective cohort study was conducted with 545 patients who diagnosed IgA nephropathy with renal biopsy in three medical centers. The primary outcome was defined as a reduction in estimated glomerular filtration rate (eGFR) of >50% or incident end‐stage renal disease (ESRD). Continuous net reclassification improvement (cNRI) and integrated discrimination improvement (IDI) were used to validate models.Results: During the median 3.6 years of follow‐up period, 53 (9.7%) renal events occurred. In multivariable Cox regression model, M1 (hazard ratio [HR], 2.22; 95% confidence interval [CI], 1.02–4.82; p = .043), T1 (HR, 2.98; 95% CI, 1.39–6.39; p = .005) and T2 (HR, 4.80; 95% CI, 2.06–11.18; p < .001) lesions were associated with increased risk of renal outcome. When applied the international prediction model, the area under curve (AUC) for 5‐year risk of renal outcome was 0.69, which was lower than previous validation and internally derived models. Moreover, cNRI and IDI analyses showed that discrimination and reclassification performance of the international model was inferior to the internally derived models.Conclusion: The international risk prediction model for IgA nephropathy showed not as good performance in Korean patients as previous validation in other ethnic group. Further validation of risk prediction model is needed for Korean patients with IgA nephropathy.